Value Bridge — ST. MARY MEDICAL CENTER
Current $-5M → Target $4M (+$9.5M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-5.0M
Current EBITDA
$4.5M
Target EBITDA
+$9.5M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$1.7M
Coding Accuracy Uplift
$1.8M
Payer Mix Optimization
$4.4M
Cost to Collect Reduction
$1.5M
Clean Claim Improvement
$1.1M
Volume & Rate Growth
$7.4M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-5M to $4M. The highest-impact lever is Volume & Rate Growth at $2.9M probability-weighted.
IC talking point: "We see $9M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $104M in equity value creation."